✦ LIBER ✦

221 Modified capecitabine regimen for advanced/metastatic gastric cancer: Final results from a multicenter phase II trial

✍ Scribed by K. Kondo; K. Chin; J. Sakamoto; H. Kojima; M. Terashima; Y. Yamamura; T. Tsujinaka; I. Hyodo

Book ID: 118620396
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90254-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and bevacizumab for non-res

Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial

✍ Stein, Alexander; Kretzschmar, Albrecht; Behringer, Dirk; Wolff, Thomas; Zimber, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 198 KB

Efficacy and tolerability of chemotherap

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

✍ Tomasello, Gianluca; Liguigli, Wanda; Poli, Rossana; Lazzarelli, Silvia; Brighen 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 220 KB

Apatinib for Chemotherapy-Refractory Adv

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

✍ Li, J.; Qin, S.; Xu, J.; Guo, W.; Xiong, J.; Bai, Y.; Sun, G.; Yang, Y.; Wang, L 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 148 KB

Results of a Phase II Trial of Cetuximab

Results of a Phase II Trial of Cetuximab plus Capecitabine/Irinotecan as First-Line Therapy for Patients with Advanced and/or Metastatic Colorectal Cancer

✍ Thomas Cartwright; Paul Kuefler; Allen Cohn; William Hyman; Maury Berger; Donald 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

751 POSTER Capecitabine (X) and etoposid

751 POSTER Capecitabine (X) and etoposide (E) for patients (pts) with locally advanced or metastatic gastric cancer: a mexican oncology Study Group phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB